top of page
Meet The Team
John Kallassy brings leadership in licensing strategy, product discovery, R&D, operations, and finance as an innovator in the fields of healthcare, human medical device, animal health, software development, and data technology. Mr. Kallassy currently serves as CEO and CFO of Bactana Corp and Torigen Pharmaceuticals, Inc, respectively. John has also served as CFO of two Nasdaq traded life science companies. Earlier in John's career, he was a FINRA licensed investment banker, and president and co-founder of the broker dealer I-Bankers Direct, LLC, where he led a team focused on raising capital and structuring financings for small and mid-size life-science and technology businesses. Prior to his investment banking career, John was the CEO of Zargis Medical Corp, where he led the development and global launch of a medical device that was awarded “2009 Product of the Year” by Popular Science magazine. In April 2011, John led the process of selling Zargis to 3M Corp, where he spent an additional year working for 3M to ensure a smooth acquisition integration. John studied pharmacology and biochemistry at the University of Leeds in England, holds a BS in biology with a concentration in chemistry from the State University of New York, and received an MBA from the Johnson School of Management at Cornell University.
John DeLorenzo has built a record of accomplishment as a media executive and the CFO of both public and private companies, where he designed, negotiated and closed over $2.5 billion in multiple financings and M&A transactions. Most recently, John is a founding partner at Aimers and operates Trenwest Development, LLC, his personal investment company. Prior to founding Aimers, John was a director at CFO Consulting Partners. Earlier in his career, John was a managing director at B. Riley & Co., where he sold a portfolio of over $200 million of debt for Wells Fargo and was the CFO of NYSE listed Entravision Communications, the owner of television, radio, and other media assets. John also served as CFO at Paxson Communications, where he negotiated its sale to NBC. Prior to Paxson, John was the CFO of Norman Lear’s Act III and played key roles in the launch of the Fox Television Network. John serves as a trustee and treasurer for Penn Medicine Princeton Health and serves on the Rider University Norm Brodsky College of Business executive advisory council. John earned his BS from Rider University and an MBA from the Johnson Graduate School of Management at Cornell University and he is a CPA.
John Lott began his career in the consumer loan business for ITT Financial Services. John held officer level positions for PHH Corp. and the current Realogy Corp. In 2004, he was hired as SVP of Corporate Development, became President and COO, and then CEO of the motorcycle parts company with $225 million in revenue. He led the company through a restructuring where Cerberus Capital Management became controlling equity holder. John then joined The Winter Group’s investment banking group, being promoted to CFO. Prior to the Winter Group, John joined Cerberus as Head of Accounting, until his selection as CFO and COO of product development company Quirky, Inc. During his tenure at Quirky, John completed investment rounds of $22 million led by RRE and Norwest Venture Partners. He received a BA in Economics from Rutgers University and an MBA from the Johnson Graduate School of Management at Cornell University.
bottom of page